Latest stories on GNLX
Genelux assumed with a Buy at Lucid Capital
The Fly56 · neutralanalyst
Genelux publishes case report from dose escalation portion of OLVI-VEC-202-SCLC
The Fly59 · neutralproduct/pr
Benchmark reiterates Genelux stock rating on cancer therapy progress
Investing.com Analyst Ratings56 · neutralanalyst
Genelux expects cash to fund operations into Q1 of 2027
The Fly48 · neutralgeneral
Genelux reports Q2 EPS (21c), consensus (20c)
The Fly52 · neutralearnings
Genelux GAAP EPS of -$0.21 misses by $0.01
Seeking Alpha34 · bearishearnings
Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates
GlobeNewswire56 · neutralearnings
Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates
Business Insider56 · neutralearnings
GENELUX Corp (GNLX) files 8-K
SEC 8-K50 · neutralgeneral